Impact of Down syndrome on the performance of neonatal screening assays for severe primary immunodeficiency diseases.
- nov 2014
- Esther de Vries
- 1
- 3895
ARTIKEL: Verstegen RH, Borte S, Bok LA, van Zwieten PH, von Döbeln U, Hammarström L, de Vries E. J Allergy Clin Immunol. 2014 Apr;133(4):1208-11.
Bijlagen
| titel | toegevoegd | door | opties | |
|---|---|---|---|---|
| Verstegen_et_al_JACI.pdf | nov 2014 |  |
Verken
Impact of respiratory tract infections on developmental skils in children with Down syndrome.
nov 2014POSTER: Verstegen RHJ, van Gameren-Oosterom HBM, Fekkes M, Dusseldorp E, de Vries E, van Wouwe JP. Imp...
Serum antibody response to tetanus toxoid in children with Down syndrome.
nov 2014POSTER: Kusters MAA, Jol-van der Zijde CM, van Tol MJD, Bolz WEA, Bok LA, Visser M, de Vries E. Europe...
Protective but lower levels of antibodies after single conjugated meningococcal serogroup C vaccination in children with Down syndrome.
nov 2014POSTER: Kusters MA, Jol-van der Zijde CM, Gijsbers R, de Vries E. European Society for Paediatric Infe...